NO20070049L - Pyrrolotriazinderivater anvendelig for behandling av hyperproliferative forstyrrelser og sykdommer assosiert med angiogenese - Google Patents
Pyrrolotriazinderivater anvendelig for behandling av hyperproliferative forstyrrelser og sykdommer assosiert med angiogeneseInfo
- Publication number
- NO20070049L NO20070049L NO20070049A NO20070049A NO20070049L NO 20070049 L NO20070049 L NO 20070049L NO 20070049 A NO20070049 A NO 20070049A NO 20070049 A NO20070049 A NO 20070049A NO 20070049 L NO20070049 L NO 20070049L
- Authority
- NO
- Norway
- Prior art keywords
- disorders
- angiogenesis
- treatment
- derivatives useful
- pyrrolotriazine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57665204P | 2004-06-03 | 2004-06-03 | |
US62653104P | 2004-11-09 | 2004-11-09 | |
PCT/US2005/019472 WO2005121147A1 (en) | 2004-06-03 | 2005-06-03 | Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20070049L true NO20070049L (no) | 2007-01-30 |
Family
ID=34971944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20070049A NO20070049L (no) | 2004-06-03 | 2007-01-03 | Pyrrolotriazinderivater anvendelig for behandling av hyperproliferative forstyrrelser og sykdommer assosiert med angiogenese |
Country Status (31)
Country | Link |
---|---|
US (3) | US7563791B2 (es) |
EP (1) | EP1765823B1 (es) |
JP (1) | JP4958772B2 (es) |
KR (1) | KR101235602B1 (es) |
CN (1) | CN1993361B (es) |
AR (1) | AR049138A1 (es) |
AT (1) | ATE462708T1 (es) |
AU (1) | AU2005252217B2 (es) |
BR (1) | BRPI0510848A (es) |
CA (1) | CA2569396C (es) |
DE (1) | DE602005020293D1 (es) |
EC (1) | ECSP067043A (es) |
ES (1) | ES2342722T3 (es) |
GT (1) | GT200500137A (es) |
HK (1) | HK1109141A1 (es) |
HN (1) | HN2005000255A (es) |
IL (1) | IL179264A0 (es) |
MA (1) | MA28689B1 (es) |
MX (1) | MX279139B (es) |
MY (1) | MY145077A (es) |
NO (1) | NO20070049L (es) |
NZ (1) | NZ551742A (es) |
PE (1) | PE20060243A1 (es) |
PH (1) | PH12006502386B1 (es) |
RU (1) | RU2401269C2 (es) |
SG (1) | SG127661A1 (es) |
SV (1) | SV2006002134A (es) |
TW (1) | TW200608979A (es) |
UY (1) | UY28931A1 (es) |
WO (1) | WO2005121147A1 (es) |
ZA (1) | ZA200700011B (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY28931A1 (es) | 2004-06-03 | 2005-12-30 | Bayer Pharmaceuticals Corp | Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis |
GB0512324D0 (en) | 2005-06-16 | 2005-07-27 | Novartis Ag | Organic compounds |
DE102005037499A1 (de) * | 2005-08-09 | 2007-02-15 | Merck Patent Gmbh | Pyrazolderivate |
US7514435B2 (en) * | 2005-11-18 | 2009-04-07 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
PE20070855A1 (es) * | 2005-12-02 | 2007-10-14 | Bayer Pharmaceuticals Corp | Derivados de 4-amino-pirrolotriazina sustituida como inhibidores de quinasas |
JP5249776B2 (ja) | 2005-12-02 | 2013-07-31 | バイエル・ヘルスケア・エルエルシー | 過剰増殖性疾患および血管新生と関連する疾患を処置するために有用な置換された4−アミノ−ピロロトリアジン誘導体 |
EP1976847B1 (en) | 2005-12-21 | 2015-06-17 | Novartis AG | Pyrimidinyl aryl urea derivatives being fgf inhibitors |
EP1882475A1 (en) * | 2006-07-26 | 2008-01-30 | Novartis AG | Method of treating disorders mediated by the fibroblast growth factor receptor |
US7912582B1 (en) * | 2007-05-03 | 2011-03-22 | Innovation Associates, Inc. | Robotic prescription filling system |
CA2698795C (en) | 2007-09-10 | 2016-04-19 | Cipla Limited | Process for the preparation of a raf kinase inhibitor and intermediates for use in the process |
MX2010003269A (es) * | 2007-09-25 | 2010-08-02 | Bayer Healthcare Llc | Derivados de pirrolotriazina utiles para tratar cancer a traves de la inhibicion de la aurora quinasa. |
EP2085397A1 (en) * | 2008-01-21 | 2009-08-05 | Esteve Quimica, S.A. | Crystalline form of abacavir |
AR074830A1 (es) | 2008-12-19 | 2011-02-16 | Cephalon Inc | Pirrolotriazinas como inhibidores de alk y jak2 |
CA2877474A1 (en) * | 2011-06-20 | 2012-12-27 | Myrexis, Inc. | Compounds and therapeutic uses thereof |
WO2013004551A1 (en) | 2011-07-01 | 2013-01-10 | Bayer Intellectual Property Gmbh | Hydroxymethylaryl-substituted pyrrolotriazines as alk1 inhibitors |
UY34484A (es) | 2011-12-15 | 2013-07-31 | Bayer Ip Gmbh | Benzotienilo-pirrolotriazinas disustituidas y sus usos |
ES2570862T3 (es) | 2011-12-15 | 2016-05-20 | Bayer Ip Gmbh | Benzotienil-pirrolotriazinas sustituidas y usos de las mismas en el tratamiento de cáncer |
CN104136439B (zh) * | 2012-02-23 | 2017-01-18 | 拜耳知识产权有限责任公司 | 取代的苯并噻吩基‑吡咯并三嗪及其用途 |
PE20170303A1 (es) * | 2014-06-17 | 2017-04-19 | Chiesi Farm Spa | Derivados de la indolizina como inhibidores de las fosfoinositido-3 quinasas |
US10053465B2 (en) | 2015-08-26 | 2018-08-21 | Incyte Corporation | Pyrrolopyrimidine derivatives as TAM inhibitors |
SG11201804901WA (en) | 2015-12-22 | 2018-07-30 | SHY Therapeutics LLC | Compounds for the treatment of cancer and inflammatory disease |
US20170252350A1 (en) | 2016-03-03 | 2017-09-07 | Cornell University | Small molecule ire1-alpha inhibitors |
LT3436461T (lt) * | 2016-03-28 | 2024-03-12 | Incyte Corporation | Pirolotriazino junginiai kaip tam inhibitoriai |
WO2018161033A1 (en) * | 2017-03-02 | 2018-09-07 | Wright, Adrian | Small molecule ire1-alpha inhibitors |
CA3066939A1 (en) | 2017-06-21 | 2018-12-27 | SHY Therapeutics LLC | Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease |
AU2018342471B2 (en) | 2017-09-27 | 2023-08-24 | Incyte Corporation | Salts of pyrrolotriazine derivatives useful as TAM inhibitors |
KR20210049088A (ko) | 2018-06-29 | 2021-05-04 | 인사이트 코포레이션 | Axl/mer 억제제의 제형 |
TW202043205A (zh) | 2018-12-31 | 2020-12-01 | 美商拜歐米富士恩有限公司 | Menin-mll相互作用之抑制劑 |
CA3125350A1 (en) | 2018-12-31 | 2020-07-09 | Biomea Fusion, Llc | Irreversible inhibitors of menin-mll interaction |
PE20220573A1 (es) * | 2019-05-13 | 2022-04-20 | Relay Therapeutics Inc | Inhibidores de fgfr y metodos de uso de los mismos |
KR20220062366A (ko) * | 2019-09-26 | 2022-05-16 | 센젠 타겟알엑스, 아이엔씨. | 치환된 방향족 융합 고리 유도체, 및 이를 포함하는 조성물, 및 이의 용도 |
EP4180433A1 (en) * | 2020-07-10 | 2023-05-17 | Beijing Findcure Biosciences, Ltd. | Triazine compound and composition and use thereof |
IL310717A (en) | 2021-08-20 | 2024-04-01 | Biomea Fusion Inc | Crystalline form of N-[4-[4-(4-morpholinyl)-7H-PYRROLO[2,3-D]PYRIMIDIN-6-YL]PHENYL]-4-[[3(R)-[(1-OXO ] -2-PROPEN-1-YL)AMINO]-1-PIPERIDINYL]METHYL]-2-PYRIDINECARBOXAMIDE, IRREVERSIBLE MENIN-MLL INHIBITOR FOR CANCER TREATMENT |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1183033T3 (da) * | 1999-05-21 | 2006-06-06 | Bristol Myers Squibb Co | Pyrrolotriazininhibitorer af kinaser |
NZ525334A (en) * | 2000-11-17 | 2005-07-29 | Bristol Myers Squibb Co | Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
WO2004013145A1 (en) * | 2002-08-02 | 2004-02-12 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
EP1694686A1 (en) | 2003-12-19 | 2006-08-30 | Takeda San Diego, Inc. | Kinase inhibitors |
UY28931A1 (es) | 2004-06-03 | 2005-12-30 | Bayer Pharmaceuticals Corp | Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis |
US7405213B2 (en) | 2005-07-01 | 2008-07-29 | Bristol-Myers Squibb Company | Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith |
US7514435B2 (en) | 2005-11-18 | 2009-04-07 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
JP5249776B2 (ja) | 2005-12-02 | 2013-07-31 | バイエル・ヘルスケア・エルエルシー | 過剰増殖性疾患および血管新生と関連する疾患を処置するために有用な置換された4−アミノ−ピロロトリアジン誘導体 |
PE20070855A1 (es) | 2005-12-02 | 2007-10-14 | Bayer Pharmaceuticals Corp | Derivados de 4-amino-pirrolotriazina sustituida como inhibidores de quinasas |
MX2010003269A (es) | 2007-09-25 | 2010-08-02 | Bayer Healthcare Llc | Derivados de pirrolotriazina utiles para tratar cancer a traves de la inhibicion de la aurora quinasa. |
-
2005
- 2005-05-30 UY UY28931A patent/UY28931A1/es not_active Application Discontinuation
- 2005-06-01 MY MYPI20052508A patent/MY145077A/en unknown
- 2005-06-01 HN HN2005000255A patent/HN2005000255A/es unknown
- 2005-06-02 PE PE2005000618A patent/PE20060243A1/es not_active Application Discontinuation
- 2005-06-02 GT GT200500137A patent/GT200500137A/es unknown
- 2005-06-02 TW TW094118090A patent/TW200608979A/zh unknown
- 2005-06-02 AR ARP050102263A patent/AR049138A1/es not_active Application Discontinuation
- 2005-06-03 SV SV2005002134A patent/SV2006002134A/es unknown
- 2005-06-03 DE DE602005020293T patent/DE602005020293D1/de active Active
- 2005-06-03 BR BRPI0510848-9A patent/BRPI0510848A/pt not_active IP Right Cessation
- 2005-06-03 EP EP05758135A patent/EP1765823B1/en active Active
- 2005-06-03 AU AU2005252217A patent/AU2005252217B2/en not_active Ceased
- 2005-06-03 US US11/596,913 patent/US7563791B2/en active Active
- 2005-06-03 ES ES05758135T patent/ES2342722T3/es active Active
- 2005-06-03 CN CN2005800260347A patent/CN1993361B/zh active Active
- 2005-06-03 CA CA2569396A patent/CA2569396C/en active Active
- 2005-06-03 WO PCT/US2005/019472 patent/WO2005121147A1/en active Application Filing
- 2005-06-03 MX MXPA06013457 patent/MX279139B/es active IP Right Grant
- 2005-06-03 AT AT05758135T patent/ATE462708T1/de not_active IP Right Cessation
- 2005-06-03 RU RU2006147237/04A patent/RU2401269C2/ru not_active IP Right Cessation
- 2005-06-03 KR KR1020077000040A patent/KR101235602B1/ko active IP Right Grant
- 2005-06-03 JP JP2007515588A patent/JP4958772B2/ja active Active
- 2005-06-03 SG SG200608387A patent/SG127661A1/en unknown
- 2005-06-03 NZ NZ551742A patent/NZ551742A/en unknown
-
2006
- 2006-11-14 IL IL179264A patent/IL179264A0/en unknown
- 2006-11-28 PH PH12006502386A patent/PH12006502386B1/en unknown
- 2006-11-30 EC EC2006007043A patent/ECSP067043A/es unknown
- 2006-12-28 MA MA29573A patent/MA28689B1/fr unknown
-
2007
- 2007-01-02 ZA ZA2007/00011A patent/ZA200700011B/en unknown
- 2007-01-03 NO NO20070049A patent/NO20070049L/no not_active Application Discontinuation
- 2007-12-24 HK HK07114075.2A patent/HK1109141A1/xx unknown
-
2009
- 2009-07-20 US US12/506,033 patent/US8338595B2/en active Active
-
2012
- 2012-12-20 US US13/722,793 patent/US20130225809A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20070049L (no) | Pyrrolotriazinderivater anvendelig for behandling av hyperproliferative forstyrrelser og sykdommer assosiert med angiogenese | |
TW200738724A (en) | Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
NO20064325L (no) | Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes | |
EP1796669A4 (en) | AMINOPIPERIDINES AS DIPEPTIDYLPEPTIDASE IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES | |
NO20053792L (no) | Heterocykly-3-sulfonylindazoler som 5-hydroksytryptamin-6 ligander | |
ECSP055783A (es) | Derivados de fenilalanina como inhibidores de dipeptidilpeptidasa para el tratamiento o prevención de diabetes | |
EP1888066A4 (en) | AMINOCYCLOHEXANES AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV FOR THE TREATMENT OR PREVENTION OF DIABETES | |
EP1841770A4 (en) | BICYCLIC PYRIMIDINES AS DIPEPTIDYLPEPTIDASE IV INHIBITORS FOR THE TREATMENT OF BZW. PREVENTION OF DIABETES | |
WO2007070434A3 (en) | Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetes | |
NO20082026L (no) | Deazapuriner som er nyttige som inhibitorer for Janus-kinaser | |
EP1921917A4 (en) | CONDENSED AMINOPIPERIDINES AS DIPEPTIDYLPEPTIDASE IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES | |
NO20065984L (no) | Forbindelser og sammensetninger som PPAR modulatorer | |
IL182218A0 (en) | Preparation and use of biphenyl-4-yl-carbonylamino and derivatives for the treatment of obesity | |
NO20072223L (no) | Glykogenfosforylaseinhibitor forbindelser med farmsoytiske preparater av disse | |
NO20055649L (no) | Substituert dihydrokinazolin med antiviale egenskaper | |
BRPI0514017A (pt) | indazóis úteis no tratamento de doenças cardiovasculares | |
NO20052380L (no) | Beta-amino-heterosykliske dipeptidylpeptidaseinhibitorer for behandling og forhindring av diabetes | |
TW200510334A (en) | Preraration and use of aryl alkyl acid derivatives for the treatment of obesity | |
DE60330485D1 (de) | Zur behandlung von diabetes | |
ATE449604T1 (de) | Pyrazolamid-derivate, diese verbindungen enthaltende zusammensetzungen und anwendungsverfahren | |
EA200600048A1 (ru) | Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором | |
EA200900828A1 (ru) | Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1 | |
NO20065983L (no) | Forbindelser og sammensetninger som PPAR modulatorer | |
NO20064732L (no) | Alfa-aminoamidderivater nyttige i behandlingen av urolige bein-syndromet og additive lidelser | |
EP1817312A4 (en) | MACROCYCLIC AMINIOPYRIDYL BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF MORBUS ALZHEIMER |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |